Oncology Corporate Profile
OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy, and other treatment alternatives.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|ImmunoPulse||immunotherapy||Triple negative Breast cancer||II|
|ImmunoPulse (+pembrolizumab)||immunotherapy||Metastatic Melanoma||II|
View additional information on product candidates here »